Carvedilol for heart failure, with care

被引：22

作者：

Cleland, JGF

Swedberg, K

机构：

[1] GOTHENBURG UNIV,OSTRA HOSP,DEPT MED,S-41685 GOTHENBURG,SWEDEN

[2] UNIV GLASGOW,CLIN RES INITIAT HEART FAILURE,GLASGOW G61 1BD,LANARK,SCOTLAND

来源：

关键词：

D O I：

10.1016/S0140-6736(96)90729-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1199 / 1201

页数：3

共 15 条

[1] Bristow MR, 1995, CIRCULATION S1, V92, P142
[2] Cohn Jay N., 1996, Journal of the American College of Cardiology, V27, p169A
[3] PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE
COHN, JN
LEVINE, TB
OLIVARI, MT
GARBERG, V
LURA, D
FRANCIS, GS
SIMON, AB
RECTOR, T
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) : 819 - 823
[4] COLUCCI WS, 1995, CIRCULATION, V92, P394
[5] CLINICAL-PHARMACOLOGY OF CARVEDILOL IN NORMAL VOLUNTEERS
CUBEDDU, LX
FUENMAYOR, N
VARIN, F
VILLAGRA, VG
COLINDRES, RE
POWELL, JR
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (01) : 31 - 44
[6] Fowler Michael B., 1996, Journal of the American College of Cardiology, V27, p169A
[7] EFFECTS OF BETA-BLOCKERS ON VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - TOLERABILITY AND SURVIVAL EFFECTS
HELD, P
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (09) : C39 - C44
[8] PACKER M, 1995, CIRCULATION S1, V92, P143
[9] PACKER M, 1995, CIRCULATION S1, V92, P142
[10] SACKNERBERNSTEI.J, 1995, CIRCULATION S1, V92, P395